The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia (UEA).

A new study, published in The Lancet Public Health, reveals that the food we eat, physical inactivity and obesity are largely to blame, as well as the Covid pandemic.

Of all the countries studied, England experienced the biggest slowdown in life expectancy.

It means that rather than looking forward to living longer than our parents or grandparents, we may find that we are dying sooner.

The team says that in order to extend our old age, we need to prioritise healthier lifestyles in our younger years – with governments urged to invest in bold public health initiatives.

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to results from the IMMUNOPRESERVE clinical trial.

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. In Ireland, there are approximately 900 cases of PC per year, and 820 PC-related deaths. Early detection of PC is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival of patients.

Survival rates, however, remain poor due to the vague nature of the symptoms associated with early-stage PC, and subsequently the late-stage of the disease at diagnosis. Now researchers from the Maher lab group, School of Medicine at Trinity College Dublin are focussing on pancreatic cystic lesions to tackle the crucial issue of identifying patients who are at high-risk of developing pancreatic cancer, to improve survival rates.